DIO TREE · raw details

Molecule for the Treatment of Ovarian Cancer · Nazareth · Founded 2022

active Pre-Seed ← back to profile
Website ↗

Highlights

IIA supported (ever)

About

Molecule for the Treatment of Ovarian Cancer

Dio Tree develops a novel small molecule for the treatment of ovarian cancer. The technology is based on inhibition of the enzyme DIO3, which is a major driver in many types of cancer, specifically ovarian cancer. The technology involves a series of small molecules targeting DIO3.

Identity

NameDIO TREE
Slugdio-tree
Former namesDIOTARGET
Type / kindstartup
Source _idTa4E1Dg5VZyTYrs7u8LCKfj5zExSiFdTK93DGlkWAhTgYd1XTe6klr

Status

Statusactive
Last update2026-05-17

Location

HQ country codeIL
HQ cityNazareth
HQ addressWadi el-Haj St 13, Nazareth, Israel

Web & social

Websitehttps://www.dio-tree.com/
LinkedInhttps://www.linkedin.com/company/90779409

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesHealthcarePatientsLife SciencesBiotechnology
Business models
B2B2C
Tags
healthcareoncologycancerfemtechbiotechnologywomen-healthbiopharmaceutical

Funding

Total raised$1.1M
Current stagePre-Seed

Raw source document

Show full JSON (0 KB) 
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}